A citation-based method for searching scientific literature

Isao Oze, Hidemi Ito, Yumiko Kasugai, Taiki Yamaji, Yuko Kijima, Tomotaka Ugai, Yoshio Kasuga, Tomoyo K Ouellette, Yukari Taniyama, Yuriko N Koyanagi, Issei Imoto, Shoichiro Tsugane, Chihaya Koriyama, Motoki Iwasaki, Keitaro Matsuo. Cancers (Basel) 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.
D Gareth R Evans, Sarah L Ingham, Andrew Baildam, Gary L Ross, Fiona Lalloo, Iain Buchan, Anthony Howell. Breast Cancer Res Treat 2013
98
100

ATM Kinase Dead: From Ataxia Telangiectasia Syndrome to Cancer.
Sabrina Putti, Alessandro Giovinazzo, Matilde Merolle, Maria Laura Falchetti, Manuela Pellegrini. Cancers (Basel) 2021
2
100

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
513
100

Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study.
Tommy Nyberg, Debra Frost, Daniel Barrowdale, D Gareth Evans, Elizabeth Bancroft, Julian Adlard, Munaza Ahmed, Julian Barwell, Angela F Brady, Carole Brewer,[...]. Eur Urol 2020
66
100



Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
100

Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA.
Claudia Piombino, Laura Cortesi, Matteo Lambertini, Kevin Punie, Giovanni Grandi, Angela Toss. J Oncol 2020
13
100

A single ataxia telangiectasia gene with a product similar to PI-3 kinase.
K Savitsky, A Bar-Shira, S Gilad, G Rotman, Y Ziv, L Vanagaite, D A Tagle, S Smith, T Uziel, S Sfez,[...]. Science 1995
100

TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial).
Nadine Tung, Banu Arun, Michele R Hacker, Erin Hofstatter, Deborah L Toppmeyer, Steven J Isakoff, Virginia Borges, Robert D Legare, Claudine Isaacs, Antonio C Wolff,[...]. J Clin Oncol 2020
50
100

Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Valentina Silvestri, Goska Leslie, Daniel R Barnes, Bjarni A Agnarsson, Kristiina Aittomäki, Elisa Alducci, Irene L Andrulis, Rosa B Barkardottir, Alicia Barroso, Daniel Barrowdale,[...]. JAMA Oncol 2020
27
100

Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Marcia Irene Canto, Jose Alejandro Almario, Richard D Schulick, Charles J Yeo, Alison Klein, Amanda Blackford, Eun Ji Shin, Abanti Sanyal, Gayane Yenokyan, Anne Marie Lennon,[...]. Gastroenterology 2018
162
100

Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies.
June-Koo Lee, Yoon-La Choi, Mijung Kwon, Peter J Park. Annu Rev Pathol 2016
72
100

Linkage of early-onset familial breast cancer to chromosome 17q21.
J M Hall, M K Lee, B Newman, J E Morrow, L A Anderson, B Huey, M C King. Science 1990
100

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
Andrew N J Tutt, Judy E Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli, Priya Rastogi, Richard D Gelber, Evandro de Azambuja, Anitra Fielding, Judith Balmaña,[...]. N Engl J Med 2021
176
100

Human Rad52 Promotes XPG-Mediated R-loop Processing to Initiate Transcription-Associated Homologous Recombination Repair.
Takaaki Yasuhara, Reona Kato, Yoshihiko Hagiwara, Bunsyo Shiotani, Motohiro Yamauchi, Shinichiro Nakada, Atsushi Shibata, Kiyoshi Miyagawa. Cell 2018
145
100

BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes.
Hiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, Liton Kumar Saha, Md Maminur Rahman, Yusuke Kiyooka, Haruna Fujiike, Andrew D Cherniack, Junji Itou, Elsa Callen Moreu,[...]. Proc Natl Acad Sci U S A 2018
44
100

Detection and Characterization of R Loop Structures.
Raquel Boque-Sastre, Marta Soler, Sonia Guil. Methods Mol Biol 2017
6
100

Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project.
Megumi Hori, Tomohiro Matsuda, Akiko Shibata, Kota Katanoda, Tomotaka Sobue, Hiroshi Nishimoto. Jpn J Clin Oncol 2015
399
100

Active and passive smoking and risk of breast cancer: a meta-analysis.
Alina Macacu, Philippe Autier, Mathieu Boniol, Peter Boyle. Breast Cancer Res Treat 2015
89
100

Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.
Jenna Lilyquist, Holly LaDuca, Eric Polley, Brigette Tippin Davis, Hermela Shimelis, Chunling Hu, Steven N Hart, Jill S Dolinsky, Fergus J Couch, David E Goldgar. Gynecol Oncol 2017
62
100

Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.
Jessica A Cintolo-Gonzalez, Danielle Braun, Amanda L Blackford, Emanuele Mazzola, Ahmet Acar, Jennifer K Plichta, Molly Griffin, Kevin S Hughes. Breast Cancer Res Treat 2017
81
100

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
Sibylle Loibl, Joyce O'Shaughnessy, Michael Untch, William M Sikov, Hope S Rugo, Mark D McKee, Jens Huober, Mehra Golshan, Gunter von Minckwitz, David Maag,[...]. Lancet Oncol 2018
323
100

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.
Nadine M Tung, Mark E Robson, Steffen Ventz, Cesar A Santa-Maria, Rita Nanda, Paul K Marcom, Payal D Shah, Tarah J Ballinger, Eddy S Yang, Shaveta Vinayak,[...]. J Clin Oncol 2020
107
100


PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response.
Srilatha Simhadri, Gabriele Vincelli, Yanying Huo, Sarah Misenko, Tzeh Keong Foo, Johanna Ahlskog, Claus S Sørensen, Gregory G Oakley, Shridar Ganesan, Samuel F Bunting,[...]. Oncogene 2019
21
100

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.
Andrew Tutt, Mark Robson, Judy E Garber, Susan M Domchek, M William Audeh, Jeffrey N Weitzel, Michael Friedlander, Banu Arun, Niklas Loman, Rita K Schmutzler,[...]. Lancet 2010
100

The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells.
André Fedier, Rolf A Steiner, Viola A Schwarz, Lenka Lenherr, Urs Haller, Daniel Fink. Int J Oncol 2003
99
100

Polymorphisms of canine BRCA2 BRC repeats affecting interaction with RAD51.
Kazuhiko Ochiai, Toshina Ishiguro-Oonuma, Yasunaga Yoshikawa, Chihiro Udagawa, Yuiko Kato, Masami Watanabe, Makoto Bonkobara, Masami Morimatsu, Toshinori Omi. Biomed Res 2015
10
100

Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study).
P A Fasching, T Link, J Hauke, F Seither, C Jackisch, P Klare, S Schmatloch, C Hanusch, J Huober, A Stefek,[...]. Ann Oncol 2021
34
100

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Harvey A Risch, John R McLaughlin, David E C Cole, Barry Rosen, Linda Bradley, Isabel Fan, James Tang, Song Li, Shiyu Zhang, Patricia A Shaw,[...]. J Natl Cancer Inst 2006
459
100

Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial.
Yung-Jue Bang, Rui-Hua Xu, Keisho Chin, Keun-Wook Lee, Se Hoon Park, Sun Young Rha, Lin Shen, Shukui Qin, Nong Xu, Seock-Ah Im,[...]. Lancet Oncol 2017
166
100

Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer.
Stian Knappskog, Ranjan Chrisanthar, Erik Løkkevik, Gun Anker, Bjørn Østenstad, Steinar Lundgren, Terje Risberg, Ingvil Mjaaland, Beryl Leirvaag, Hrvoje Miletic,[...]. Breast Cancer Res 2012
48
100


Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
100

Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers.
Meenakshi Anurag, Nindo Punturi, Jeremy Hoog, Matthew N Bainbridge, Matthew J Ellis, Svasti Haricharan. Clin Cancer Res 2018
39
100

Homologous recombination proficiency in ovarian and breast cancer patients.
Justin Fortune Creeden, Nisha S Nanavaty, Katelyn R Einloth, Cassidy E Gillman, Laura Stanbery, Danae M Hamouda, Lance Dworkin, John Nemunaitis. BMC Cancer 2021
3
100

Mammary development meets cancer genomics.
Aleix Prat, Charles M Perou. Nat Med 2009
135
100

The effect of neoadjuvant platinum-based chemotherapy in BRCA mutated triple negative breast cancers -systematic review and meta-analysis.
Olga Caramelo, Cristina Silva, Francisco Caramelo, Cristina Frutuoso, Teresa Almeida-Santos. Hered Cancer Clin Pract 2019
30
100

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
D Malkin, F P Li, L C Strong, J F Fraumeni, C E Nelson, D H Kim, J Kassel, M A Gryka, F Z Bischoff, M A Tainsky. Science 1990
100

Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.
Anna M Chiarelli, Kristina M Blackmore, Derek Muradali, Susan J Done, Vicky Majpruz, Ashini Weerasinghe, Lucia Mirea, Andrea Eisen, Linda Rabeneck, Ellen Warner. J Natl Cancer Inst 2020
24
100

Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.
Bing Xia, Qing Sheng, Koji Nakanishi, Akihiro Ohashi, Jianmin Wu, Nicole Christ, Xinggang Liu, Maria Jasin, Fergus J Couch, David M Livingston. Mol Cell 2006
569
100

Genotype-phenotype associations in Fanconi anemia: A literature review.
Moisés O Fiesco-Roa, Neelam Giri, Lisa J McReynolds, Ana F Best, Blanche P Alter. Blood Rev 2019
60
100

Can we prevent BRCA1-associated breast cancer by RANKL inhibition?
Joanne Kotsopoulos, Christian Singer, Steven A Narod. Breast Cancer Res Treat 2017
20
100

Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.
Maria C Villarroel, N V Rajeshkumar, Ignacio Garrido-Laguna, Ana De Jesus-Acosta, Siân Jones, Anirban Maitra, Ralph H Hruban, James R Eshleman, Alison Klein, Daniel Laheru,[...]. Mol Cancer Ther 2011
180
100

RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.
Emma Nolan, François Vaillant, Daniel Branstetter, Bhupinder Pal, Göknur Giner, Lachlan Whitehead, Sheau W Lok, Gregory B Mann, Kathy Rohrbach, Li-Ya Huang,[...]. Nat Med 2016
167
100


Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.
Kathryn P Pennington, Tom Walsh, Maria I Harrell, Ming K Lee, Christopher C Pennil, Mara H Rendi, Anne Thornton, Barbara M Norquist, Silvia Casadei, Alexander S Nord,[...]. Clin Cancer Res 2014
562
100

Targeting the double-strand DNA break repair pathway as a therapeutic strategy.
Christopher J Lord, Michelle D Garrett, Alan Ashworth. Clin Cancer Res 2006
71
100

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.
D W Bell, J M Varley, T E Szydlo, D H Kang, D C Wahrer, K E Shannon, M Lubratovich, S J Verselis, K J Isselbacher, J F Fraumeni,[...]. Science 1999
668
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.